Cancer screening in elderly patients: a framework for individualized decision making.

By L. Walter, K. Covinsky. Journal of the American Medical Association (JAMA), 2001

1,008 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Oncology

View Paper: https://www.semanticscholar.org/paper/aca07a935a4236bf122478bd97093ebb5459dedf

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

Citations in the corpus

Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands (2004, background): “Therefore, mammography rates should not decrease with advancing age among women in the upper health quartiles who are in their 70s or 80s (8).”
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. (2020, methodology): “Country-specific life tables are available; however, survival must be individualised [78] based, for example, on gait speed [79] or using tools such as the Cumulative Illness Score Rating — Geriatrics (CISR-G) [80], the Charlson Comorbidity Index (CCI) [81], or the clinical frailty score [82].”
Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. (2005, background): “We examined the concepts of competing risks and burden of treatment for patients and caregivers because these issues are central in the care of older adults with multiple diseases.(49,50) Two investigators (C.”
Development and validation of a prognostic index for 4-year mortality in older adults. (2006, background): “Because the benefits of cancer screening are not realized for 5 years, recent cancer screening guidelines call for targeting screening to individuals with a life expectancy of more than 5 years.(4-6,35) Our index may be useful in identifying older low-risk patients who may benefit from screening as ”
Age-Related Diseases and Clinical and Public Health Implications for the 85 Years Old and Over Population (2017, background): “At any age, life expectancy is quite variable in older adults, based on comorbidities and other factors (29).”
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. (2024, positive): “Country-speciﬁc life tables are available; however, survival must be individualised [57] based, for example, on gait speed [58] or using tools such as the Cumulative Illness Score Rating—Geriatrics (CISR-G) [59], the Charlson Comorbidity Index (CCI) [60], or the clinical frailty score [61].”